| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |